E25BIO INC.

Profile

Company Names

E25BIO INC.

Addresses

501 MASSACHUSETTS AVENUE, OFFICE 221, CAMBRIDGE, MA 02139

Phone Numbers

857-277-9050

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$6,799,970.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2021-05-17 
$500,000.00 
$500,000.00 
$0.00 
 
3
2020-05-05 
$2,000,000.00 
$2,000,000.00 
$0.00 
 
2
2020-03-11 
$2,000,000.00 
$3,000,000.00 
$1,000,000.00 
 
1
2019-08-09 
$2,299,970.00 
$2,299,970.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
IRENE 
 
BOSCH 
EXECUTIVE OFFICER, DIRECTOR
E25BIO INC.
PRASHANT 
 
CHOUTA 
EXECUTIVE OFFICER, DIRECTOR
E25BIO INC.
ANN 
 
DEWITT 
DIRECTOR
IMMUNEXCITE, INC.   |  KYTOPEN CORP.   |  LUCY THERAPEUTICS, INC.   |  CAMBRIDGE CROPS, INC.   |  SYZYGY PLASMONICS INC.   |  E25BIO INC.   |  QUAISE, INC.   |  VAXESS TECHNOLOGIES, INC.   |  DROPLET BIOSCIENCES, INC.   |  BIOBOT ANALYTICS, INC.   |  QUAISE ENERGY, INC.   |  KANO THERAPEUTICS INC.   |  TERRESTRIAL BIO, INC.
SHADAH 
 
ENRIQUE 
EXECUTIVE OFFICER
E25BIO INC.
BOBBY 
 
HERRARA 
EXECUTIVE OFFICER
E25BIO INC.
BOBBY 
BROOKE 
HERRERA 
EXECUTIVE OFFICER
E25BIO INC.
JEFF 
 
TAKLE 
EXECUTIVE OFFICER, DIRECTOR
E25BIO INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-06-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2021-05-17 
2020-05-19
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2020-05-05 
2020-03-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
 
2020-03-11 
2019-08-22
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-08-09 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#